Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor Historically Known for High EphA2 Expression|Urothelial Cancer|Ovarian Cancer|Non-small Cell Lung Cancer|Head and Neck Cancer|Triple Negative Breast Cancer|Gastric/Upper Gastrointestinal Cancer
Interventions: DRUG: BT5528|DRUG: Nivolumab
Sponsor: BicycleTx Limited